Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia

Lawrence J. Shampine(Durham VA Medical Center)
Neuropsychopharmacology
April 1, 2009
Cited by 190


Related Papers

No related papers found

Powered by citation graph analysis